Datapharm has strong relations with all Phase I units in Australia, currently running Phase I studies at three of these sites, providing Data Management and Monitoring services. Datapharm has customised, or been involved in, over 50 phase I clinical trials set up in the hospital setting. We’ve been able to provide PK calculations and analyses for bioavailability and bioequivalence studies utilizing our own group.
Datapharm can support your phase III and IV research in Australia and New Zealand. Datapharm Australia is building an international group of CROs and specialist service providers in the DAI-SYS group to support global studies and clinical trials.